| Summary: | Over the last decade the biotech industry has been facing an increasingly turbulent environment (Howseman, 2006). In recent years, the technological focus has shifted dramatically (Williams, 2007). Biotechnology companies have responded to these conditions by forming a wide range of collaborative partnerships, which may vary by underlying rationale, time frame, and form. The number of alliances within the Biotech sector in 2007 more than doubled compared to 2005, with a clear dominance of pharma-biotech deals (Ernst& Young, 2007).
This paper presents a case study within the biotech industry. One company involved in several collaborative ventures was selected for thorough examination. The goal was to compare the behaviour of this particular firm with the findings of the academic literature. To that end, I specifically explored the firm's collaborative processes, the determinants for achieving success, and the opportunities for technological development and inter-organizational learning. Ultimately, the study will support the findings of prior research that firms are increasingly relying on knowledge acquired from other firms to enhance the growth and development of their own productive capacity.
|
|---|